Target type: biologicalprocess
Any process that stops, prevents or reduces the frequency, rate or extent of protein tyrosine phosphatase activity. [GO_REF:0000059, GOC:TermGenie, PMID:11129957]
Negative regulation of protein tyrosine phosphatase activity is a crucial biological process that tightly controls the activity of protein tyrosine phosphatases (PTPs). PTPs are enzymes that remove phosphate groups from tyrosine residues on proteins, a process known as dephosphorylation. This dephosphorylation event often acts as a "switch" to turn off signaling pathways, thereby regulating diverse cellular processes like cell growth, differentiation, and immune responses.
The negative regulation of PTP activity ensures proper balance and prevents uncontrolled signaling. This regulation is achieved through a variety of mechanisms, including:
1. **Inhibitory proteins:** Specific proteins directly bind to and inhibit PTPs. These inhibitors can be either competitive or non-competitive, blocking the active site of the PTP or altering its conformation, respectively. Examples include:
* **PTP1B inhibitors:** These inhibitors are known to block the activity of PTP1B, an important regulator of insulin signaling.
* **SHP-2 inhibitors:** SHP-2 is a PTP involved in various signaling pathways, and its inhibitors are being explored as potential cancer therapies.
2. **Post-translational modifications:** PTPs can be modified by phosphorylation, acetylation, or ubiquitination, which can alter their activity. These modifications can be triggered by various stimuli and often lead to the inactivation of PTPs.
3. **Protein-protein interactions:** PTPs can interact with other proteins, forming complexes that either enhance or inhibit their activity. This interaction can be regulated by changes in cellular conditions or by the presence of specific signaling molecules.
4. **Subcellular localization:** The localization of PTPs within the cell can influence their activity. Some PTPs are restricted to specific compartments, such as the nucleus or the plasma membrane, where they can regulate specific signaling events.
5. **Oxidative stress:** Oxidative stress can directly inactivate PTPs by oxidizing their catalytic cysteine residues. This mechanism contributes to the dysregulation of signaling pathways observed in various disease states.
Overall, the negative regulation of protein tyrosine phosphatase activity is a complex process involving multiple mechanisms. This fine-tuning of PTP activity is essential for maintaining proper cellular function and for responding appropriately to diverse stimuli. Dysregulation of PTP activity is often linked to various diseases, highlighting the importance of understanding and controlling this critical biological process.'
"
Protein | Definition | Taxonomy |
---|---|---|
Galectin-3 | A galectin-3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17931] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
lactose | beta-lactose : The beta-anomer of lactose. lactose : A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form. Lactose: A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. | lactose | |
methyl alpha-d-galactopyranoside | methyl alpha-D-galactoside : An alpha-D-galactoside having a methyl substituent at the anomeric position. methyl-galactopyranoside: structure in first source | alpha-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
methyl beta-galactoside | methyl beta-D-galactoside : A beta-D-galactopyranoside having a methyl substituent at the anomeric position. methyl beta-galactoside: RN given refers to (beta-D)-isomer methyl galactoside : A methyl glycoside in which the H of the OH group on C-1 of galactose is replaced by a methyl group. | beta-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
thiodigalactoside | thiodigalactoside: RN given refers to beta-D-galactopyranoside (D-Gal)-isomer | ||
methyl lactoside | beta-D-Gal-(1->4)-beta-D-Glc-OMe : A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position. | disaccharide derivative; methyl glycoside | |
n-acetyllactosamine | N-acetyllactosamine : A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. N-acetyllactosamine: RN given refers to D-isomer | beta-D-Galp-(1->4)-D-GlcpNAc | |
galactose | alpha-D-galactoside : Any D-galactoside having alpha-configuration at its anomeric centre. | D-galactopyranose | mouse metabolite |
galactal | galactal: RN given refers to cpd with unspecified isomeric designation; structure | anhydrohexose; glycal | |
pf-2545920 |